首页 › 基金 › GILEAD SCIENCES, INC. › RCUS

GILEAD SCIENCES, INC. 对 RCUS 的持仓历史

ARCUS BIOSCIENCES INC · 医疗保健

GILEAD SCIENCES, INC. 在 Q3 2026 的 13F 申报中披露持有 RCUS(ARCUS BIOSCIENCES INC)31,424,760 股,市值约 US$811.7M,约占其申报组合的 55.45%,在其申报持仓中市值排名第 1 位。 GILEAD SCIENCES, INC. 最近 8 个申报季度中有 8 个季度披露了 RCUS 持仓,最早可追溯至 Q4 2024。

最新持仓 (Q3 2026)31.42M 股
申报持仓市值$811.70M
组合权重55.45%
首次申报Q4 2024
最近变动持有
更新于2026-11-06

最后更新: 2026-11-06 · 来源: SEC EDGAR Form 13F-HR

GILEAD SCIENCES, INC. 对 RCUS 的持仓演变

GILEAD SCIENCES, INC. 于 Q4 2024 首次披露 RCUS 持仓:30,061,124 股(约 US$447.6M)。 该持仓在 Q2 2026 达到峰值 31,424,760 股,市值约 US$968.8M。 在 8 次申报中,GILEAD SCIENCES, INC. 1 次增持、0 次减持、6 次保持不变。 最近一期申报(Q3 2026)显示持股 31,424,760 股、市值约 US$811.7M。

逐季持仓明细

季度股数金额变化
Q4 2024 30.06M $447.61M 新进
Q1 2025 31.42M $246.68M 增持
Q2 2025 31.42M $255.80M 持有
Q3 2025 31.42M $427.38M 持有
Q4 2025 31.42M $748.85M 持有
Q1 2026 31.42M $678.77M 持有
Q2 2026 31.42M $968.83M 持有
Q3 2026 31.42M $811.70M 持有

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 RCUS 与 13F 数据

RCUS(ARCUS BIOSCIENCES INC)属于医疗保健行业。我们追踪的基金中还有 46 只申报持有 RCUS,申报仓位最大的包括:MONTANOVA CAPITAL, LLC (US$147.3M), Siren, L.L.C. (US$74.6M), SAMLYN CAPITAL, LLC (US$47.7M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 RCUS 的基金

查看 RCUS 的全部基金持有人 →

常见问题

How long has GILEAD SCIENCES, INC. held RCUS?

GILEAD SCIENCES, INC. has disclosed RCUS holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is GILEAD SCIENCES, INC.'s current position in RCUS?

As of Q3 2026, GILEAD SCIENCES, INC. holds 31.42M shares of RCUS (ARCUS BIOSCIENCES INC), valued at $811.70M, representing 55.45% of its reported portfolio and ranking #1.

Has GILEAD SCIENCES, INC. been buying or selling RCUS?

In the latest 13F filing (Q3 2026), GILEAD SCIENCES, INC. held unchanged its position in RCUS. The position peaked in Q2 2026 at 31.42M shares.

Which other funds hold RCUS?

Other major institutional holders of RCUS include MONTANOVA CAPITAL, LLC, Siren, L.L.C., SAMLYN CAPITAL, LLC, among 46 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.